Advertisement Albemarle Names New President - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Albemarle Names New President

Albemarle, a developer, manufacturer and marketer of specialty chemicals for pharmaceuticals, has appointed Luke Kissam as the new president. In this role, Mr Kissam will oversee all aspects of the company's global business and operational activities.

An industry veteran with over 20 years of experience, Mr Kissam joined Albemarle as VP of General Counsel and Secretary in 2003. Since that time, he has held several roles.

Most recently, he served as senior vice president of manufacturing and law, and corporate secretary and was named executive vice president in May 2009.

Mark Rohr, chairman and chief executive officer of Albemarle, said: “This is a well-deserved promotion that recognizes Luke’s past achievements, as well as his current leadership on key strategic initiatives. As we enter a recovery period for the world economies, Luke’s broad leadership capabilities will help accelerate our globalization efforts and success as an innovative solutions provider for our expanding customer base.”